logo

For the Inventor, By the Inventor

Abingdon, United Kingdom

Peter Weber

This inventor holds 7 USPTO granted patents and 1 EPO patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2008-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Weber. Retrieved from https://idiyas.com/inventor/peter-weber-ky8yzw99

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 14.3

 

Average Co-Inventor Count = 7.2

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Abingdon Oxfordshire, GB (2010)
  • Abingdon, GB (2008 - 2016)

Company Filing History:

goldMedal7 out of 1,167 
 
Vertex Pharmaceuticals, Inc.
 patents

Years Active: 2008-2016

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 9499497 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase (2016-11-22),
2. 9073875 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase (2015-07-07),
3. 8124392 - Crystal structure of Aurora-2 protein and binding pockets thereof (2012-02-28),
4. 7960398 - Regulation of TNF-alpha (2011-06-14),
5. 7809541 - Crystal structure of aurora-2 protein and binding pockets thereof (2010-10-05),
6. 7807659 - Caspase inhibitors and uses thereof (2010-10-05),
7. 7361492 - Crystal structure of aurora-2 protein and binding pockets thereof (2008-04-22),

Title: Innovations of Peter Weber

Introduction

Peter Weber is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work primarily focuses on compounds that serve as inhibitors of indoleamine 2,3-dioxygenase (IDO), which have important applications in treating various diseases.

Latest Patents

Among his latest patents, Peter Weber has developed compounds that are useful as inhibitors of indoleamine 2,3-dioxygenase. These inventions include pharmaceutically acceptable compositions that comprise these compounds, methods for treating various diseases, and processes for preparing these compounds. The compounds are designed to be used in in vitro applications, showcasing their versatility and potential impact in medical treatments.

Career Highlights

Peter Weber is currently associated with Vertex Pharmaceuticals, Inc., where he continues to innovate and contribute to the advancement of pharmaceutical sciences. His expertise in developing IDO inhibitors has positioned him as a key figure in this specialized area of research.

Collaborations

Peter has collaborated with notable colleagues such as Ronald Marcellus Knegtel and Andrew Miller, enhancing the scope and impact of his research through teamwork and shared expertise.

Conclusion

Peter Weber's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work on IDO inhibitors not only showcases his creativity but also his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…